BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 29526822)

  • 1. Breathprinting and Early Diagnosis of Lung Cancer.
    Rocco G; Pennazza G; Santonico M; Longo F; Rocco R; Crucitti P; Antonelli Incalzi R
    J Thorac Oncol; 2018 Jul; 13(7):883-894. PubMed ID: 29526822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Every breath you take: The value of the electronic nose (e-nose) technology in the early detection of lung cancer.
    Rocco G
    J Thorac Cardiovasc Surg; 2018 Jun; 155(6):2622-2625. PubMed ID: 29602425
    [No Abstract]   [Full Text] [Related]  

  • 3. Volatile signature for the early diagnosis of lung cancer.
    Gasparri R; Santonico M; Valentini C; Sedda G; Borri A; Petrella F; Maisonneuve P; Pennazza G; D'Amico A; Di Natale C; Paolesse R; Spaggiari L
    J Breath Res; 2016 Feb; 10(1):016007. PubMed ID: 26857451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex and Smoking Status Effects on the Early Detection of Early Lung Cancer in High-Risk Smokers Using an Electronic Nose.
    McWilliams A; Beigi P; Srinidhi A; Lam S; MacAulay CE
    IEEE Trans Biomed Eng; 2015 Aug; 62(8):2044-54. PubMed ID: 25775482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential of the Electronic Nose for the Detection of Respiratory Diseases with and without Infection.
    Licht JC; Grasemann H
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33321951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expiratory flow rate, breath hold and anatomic dead space influence electronic nose ability to detect lung cancer.
    Bikov A; Hernadi M; Korosi BZ; Kunos L; Zsamboki G; Sutto Z; Tarnoki AD; Tarnoki DL; Losonczy G; Horvath I
    BMC Pulm Med; 2014 Dec; 14():202. PubMed ID: 25510554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of the PEN3 e-nose in the screening of colorectal cancer and polyps.
    Altomare DF; Porcelli F; Picciariello A; Pinto M; Di Lena M; Caputi Iambrenghi O; Ugenti I; Guglielmi A; Vincenti L; De Gennaro G
    Tech Coloproctol; 2016 Jun; 20(6):405-409. PubMed ID: 27000856
    [No Abstract]   [Full Text] [Related]  

  • 8. Breathprinting analysis and biomimetic sensor technology to detect lung cancer.
    Vanstraelen S; Jones DR; Rocco G
    J Thorac Cardiovasc Surg; 2023 Aug; 166(2):357-361.e1. PubMed ID: 36997463
    [No Abstract]   [Full Text] [Related]  

  • 9. Electronic Nose Analysis of Exhaled Breath Volatiles to Identify Lung Cancer Cases: A Systematic Review.
    Swanson B; Fogg L; Julion W; Arrieta MT
    J Assoc Nurses AIDS Care; 2020; 31(1):71-79. PubMed ID: 31860595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constructing an E-Nose Using Metal-Ion-Induced Assembly of Graphene Oxide for Diagnosis of Lung Cancer via Exhaled Breath.
    Chen Q; Chen Z; Liu D; He Z; Wu J
    ACS Appl Mater Interfaces; 2020 Apr; 12(15):17713-17724. PubMed ID: 32203649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BIONOTE e-nose technology may reduce false positives in lung cancer screening programmes†.
    Rocco R; Incalzi RA; Pennazza G; Santonico M; Pedone C; Bartoli IR; Vernile C; Mangiameli G; La Rocca A; De Luca G; Rocco G; Crucitti P
    Eur J Cardiothorac Surg; 2016 Apr; 49(4):1112-7; discussion 1117. PubMed ID: 26385981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid recognition of volatile organic compounds with colorimetric sensor arrays for lung cancer screening.
    Zhong X; Li D; Du W; Yan M; Wang Y; Huo D; Hou C
    Anal Bioanal Chem; 2018 Jun; 410(16):3671-3681. PubMed ID: 29654337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electronic Nose Technology in Respiratory Diseases.
    Dragonieri S; Pennazza G; Carratu P; Resta O
    Lung; 2017 Apr; 195(2):157-165. PubMed ID: 28238110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Framework with High Diagnostic Sensitivity for Lung Cancer Detection by Electronic Nose.
    Lu B; Fu L; Nie B; Peng Z; Liu H
    Sensors (Basel); 2019 Dec; 19(23):. PubMed ID: 31817006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the early detection of lung cancer using analysis of volatile organic compounds: from imaging to sensors.
    Li W; Liu HY; Jia ZR; Qiao PP; Pi XT; Chen J; Deng LH
    Asian Pac J Cancer Prev; 2014; 15(11):4377-84. PubMed ID: 24969857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.
    Dragonieri S; Annema JT; Schot R; van der Schee MP; Spanevello A; CarratĂș P; Resta O; Rabe KF; Sterk PJ
    Lung Cancer; 2009 May; 64(2):166-70. PubMed ID: 18834643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of volatile organic compounds in exhaled breath to screen lung cancer: a systematic review.
    Hua Q; Zhu Y; Liu H
    Future Oncol; 2018 Jul; 14(16):1647-1662. PubMed ID: 29939068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breath testing as a method for detecting lung cancer.
    Taivans I; Bukovskis M; Strazda G; Jurka N
    Expert Rev Anticancer Ther; 2014 Feb; 14(2):121-3. PubMed ID: 24467216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How well does your e-nose detect cancer? Application of artificial breath analysis for performance assessment.
    Martin JDM; Claudia F; Romain AC
    J Breath Res; 2024 Jan; 18(2):. PubMed ID: 38211310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volatolomic urinary profile analysis for diagnosis of the early stage of lung cancer.
    Gasparri R; Capuano R; Guaglio A; Caminiti V; Canini F; Catini A; Sedda G; Paolesse R; Di Natale C; Spaggiari L
    J Breath Res; 2022 Sep; 16(4):. PubMed ID: 35952625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.